Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001104659-19-014720
Filing Date
2019-03-14
Accepted
2019-03-14 08:07:15
Documents
13
Period of Report
2019-03-14

Document Format Files

Seq Description Document Type Size
1 6-K a19-3601_46k.htm 6-K 82442
2 GRAPHIC g36014mmi001.gif GRAPHIC 505920
3 GRAPHIC g36014mmi002.gif GRAPHIC 429119
4 GRAPHIC g36014mmi003.gif GRAPHIC 469927
5 GRAPHIC g36014mmi004.gif GRAPHIC 388623
6 GRAPHIC g36014mmi005.gif GRAPHIC 242436
7 GRAPHIC g36014mmi006.gif GRAPHIC 419527
8 GRAPHIC g36014mmi007.gif GRAPHIC 393358
9 GRAPHIC g36014mmi008.gif GRAPHIC 379787
10 GRAPHIC g36014mmi009.gif GRAPHIC 306246
11 GRAPHIC g36014mmi010.gif GRAPHIC 509886
12 GRAPHIC g36014mmi011.gif GRAPHIC 356769
13 GRAPHIC g36014mmi012.gif GRAPHIC 210046
  Complete submission text file 0001104659-19-014720.txt   6434434
Mailing Address 1 FRANCIS CRICK AVENUE CAMBRIDGE BIOMEDICAL CAMPUS CAMBRIDGE X0 CB2 0AA
Business Address 1 FRANCIS CRICK AVENUE CAMBRIDGE BIOMEDICAL CAMPUS CAMBRIDGE X0 CB2 0AA 011 44 20 7304 5000
ASTRAZENECA PLC (Filer) CIK: 0000901832 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-11960 | Film No.: 19679767
SIC: 2834 Pharmaceutical Preparations